Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest

(1) Background: Acute kidney injury (AKI) is a common complication following thoracic aortic surgery (TAS), with moderate hypothermic circulatory arrest (MHCA). However, prediction of AKI with classical tools remains uncertain. Therefore, it was the aim of the present study to evaluate the role of n...

Full description

Bibliographic Details
Main Authors: Kevin Pilarczyk, Bernd Panholzer, Katharina Huenges, Mohamed Salem, Toni Jacob, Jochen Cremer, Assad Haneya
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/4/1024
_version_ 1797479106475982848
author Kevin Pilarczyk
Bernd Panholzer
Katharina Huenges
Mohamed Salem
Toni Jacob
Jochen Cremer
Assad Haneya
author_facet Kevin Pilarczyk
Bernd Panholzer
Katharina Huenges
Mohamed Salem
Toni Jacob
Jochen Cremer
Assad Haneya
author_sort Kevin Pilarczyk
collection DOAJ
description (1) Background: Acute kidney injury (AKI) is a common complication following thoracic aortic surgery (TAS), with moderate hypothermic circulatory arrest (MHCA). However, prediction of AKI with classical tools remains uncertain. Therefore, it was the aim of the present study to evaluate the role of new biomarkers in patients after MHCA. (2) Methods: 101 consecutive patients were prospectively enrolled. Measurements of urinary [TIMP-2]*[IGFBP7] and Cystatin C in the blood were performed perioperatively. Primary endpoint was the occurrence of AKI stage 2 or 3 (KDIGO-classification) within 48 h after surgery (AKI group). (3) Results: Mean age of patients was 69.1 ± 10.9 years, 35 patients were female (34%), and 13 patients (13%) met the primary endpoint. Patients in the AKI group had a prolonged ICU-stay (6.9 ± 7.4 days vs. 2.5 ± 3.1 days, <i>p</i> < 0.001) as well as a higher 30-day-mortality (9/28 vs. 1/74, <i>p</i> < 0.001). Preoperative serum creatinine (169.73 ± 148.97 μmol/L vs. 89.74 ± 30.04 μmol/L, <i>p</i> = 0.027) as well as Cystatin C (2.41 ± 1.54 mg/L vs. 1.13 ± 0.35 mg/L, <i>p</i> = 0.029) were higher in these patients. [TIMP-2]*[IGFBP7] increased significantly four hours after surgery (0.6 ± 0.69 mg/L vs. 0.37 ± 0.56 mg/L, <i>p</i> = 0.03) in the AKI group. Preoperative Cystatin C (AUC 0.828, <i>p</i> < 0.001) and serum creatinine (AUC 0.686, <i>p</i> = 0.002) as well as [TIMP-2]*[IGFBP7] 4 h after surgery (AUC 0.724, <i>p</i> = 0.020) were able to predict postoperative AKI. The predictive capacity of Cystatin C was superior to serum creatinine (<i>p</i> = 0.0211) (4) Conclusion: Cystatin C represents a very sensitive and specific biomarker to predict AKI in patients undergoing thoracic surgery with MHCA even before surgery, whereas the predictive capacity of [TIMP-2]*[IGFBP7] is only moderate and inferior to that of serum creatinine.
first_indexed 2024-03-09T21:40:58Z
format Article
id doaj.art-4c9835391a1a44b0b427d1907ef90878
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T21:40:58Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-4c9835391a1a44b0b427d1907ef908782023-11-23T20:30:31ZengMDPI AGJournal of Clinical Medicine2077-03832022-02-01114102410.3390/jcm11041024Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory ArrestKevin Pilarczyk0Bernd Panholzer1Katharina Huenges2Mohamed Salem3Toni Jacob4Jochen Cremer5Assad Haneya6Department of Intensive Care Medicine, Imland Klinik Rendsburg, 24768 Rendsburg, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, GermanyDepartment of Cardiovascular Surgery, University of Schleswig-Holstein, 24105 Kiel, Germany(1) Background: Acute kidney injury (AKI) is a common complication following thoracic aortic surgery (TAS), with moderate hypothermic circulatory arrest (MHCA). However, prediction of AKI with classical tools remains uncertain. Therefore, it was the aim of the present study to evaluate the role of new biomarkers in patients after MHCA. (2) Methods: 101 consecutive patients were prospectively enrolled. Measurements of urinary [TIMP-2]*[IGFBP7] and Cystatin C in the blood were performed perioperatively. Primary endpoint was the occurrence of AKI stage 2 or 3 (KDIGO-classification) within 48 h after surgery (AKI group). (3) Results: Mean age of patients was 69.1 ± 10.9 years, 35 patients were female (34%), and 13 patients (13%) met the primary endpoint. Patients in the AKI group had a prolonged ICU-stay (6.9 ± 7.4 days vs. 2.5 ± 3.1 days, <i>p</i> < 0.001) as well as a higher 30-day-mortality (9/28 vs. 1/74, <i>p</i> < 0.001). Preoperative serum creatinine (169.73 ± 148.97 μmol/L vs. 89.74 ± 30.04 μmol/L, <i>p</i> = 0.027) as well as Cystatin C (2.41 ± 1.54 mg/L vs. 1.13 ± 0.35 mg/L, <i>p</i> = 0.029) were higher in these patients. [TIMP-2]*[IGFBP7] increased significantly four hours after surgery (0.6 ± 0.69 mg/L vs. 0.37 ± 0.56 mg/L, <i>p</i> = 0.03) in the AKI group. Preoperative Cystatin C (AUC 0.828, <i>p</i> < 0.001) and serum creatinine (AUC 0.686, <i>p</i> = 0.002) as well as [TIMP-2]*[IGFBP7] 4 h after surgery (AUC 0.724, <i>p</i> = 0.020) were able to predict postoperative AKI. The predictive capacity of Cystatin C was superior to serum creatinine (<i>p</i> = 0.0211) (4) Conclusion: Cystatin C represents a very sensitive and specific biomarker to predict AKI in patients undergoing thoracic surgery with MHCA even before surgery, whereas the predictive capacity of [TIMP-2]*[IGFBP7] is only moderate and inferior to that of serum creatinine.https://www.mdpi.com/2077-0383/11/4/1024acute kidney injuryhypothermic circulatory arrestthoracic aortic surgerybiomarkersCystatincell cycle arrest markers
spellingShingle Kevin Pilarczyk
Bernd Panholzer
Katharina Huenges
Mohamed Salem
Toni Jacob
Jochen Cremer
Assad Haneya
Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
Journal of Clinical Medicine
acute kidney injury
hypothermic circulatory arrest
thoracic aortic surgery
biomarkers
Cystatin
cell cycle arrest markers
title Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
title_full Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
title_fullStr Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
title_full_unstemmed Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
title_short Prediction of Acute Kidney Injury by Cystatin C and [TIMP-2]*[IGFBP7] after Thoracic Aortic Surgery with Moderate Hypothermic Circulatory Arrest
title_sort prediction of acute kidney injury by cystatin c and timp 2 igfbp7 after thoracic aortic surgery with moderate hypothermic circulatory arrest
topic acute kidney injury
hypothermic circulatory arrest
thoracic aortic surgery
biomarkers
Cystatin
cell cycle arrest markers
url https://www.mdpi.com/2077-0383/11/4/1024
work_keys_str_mv AT kevinpilarczyk predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT berndpanholzer predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT katharinahuenges predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT mohamedsalem predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT tonijacob predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT jochencremer predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest
AT assadhaneya predictionofacutekidneyinjurybycystatincandtimp2igfbp7afterthoracicaorticsurgerywithmoderatehypothermiccirculatoryarrest